FBIOX vs. XBI
Compare and contrast key facts about Fidelity Select Biotechnology Portfolio (FBIOX) and SPDR S&P Biotech ETF (XBI).
FBIOX is managed by Fidelity. It was launched on Dec 16, 1985. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBIOX or XBI.
Correlation
The correlation between FBIOX and XBI is 0.94, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FBIOX vs. XBI - Performance Comparison
Key characteristics
FBIOX:
-0.44
XBI:
-0.74
FBIOX:
-0.46
XBI:
-0.89
FBIOX:
0.94
XBI:
0.90
FBIOX:
-0.22
XBI:
-0.32
FBIOX:
-1.08
XBI:
-1.99
FBIOX:
8.67%
XBI:
9.20%
FBIOX:
21.34%
XBI:
24.94%
FBIOX:
-71.96%
XBI:
-63.89%
FBIOX:
-42.78%
XBI:
-57.97%
Returns By Period
In the year-to-date period, FBIOX achieves a -11.69% return, which is significantly higher than XBI's -18.95% return. Over the past 10 years, FBIOX has underperformed XBI with an annualized return of -3.44%, while XBI has yielded a comparatively higher -0.30% annualized return.
FBIOX
-11.69%
-14.32%
-19.50%
-10.03%
-1.77%
-3.44%
XBI
-18.95%
-16.39%
-24.22%
-18.94%
-2.20%
-0.30%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBIOX vs. XBI - Expense Ratio Comparison
FBIOX has a 0.69% expense ratio, which is higher than XBI's 0.35% expense ratio.
Risk-Adjusted Performance
FBIOX vs. XBI — Risk-Adjusted Performance Rank
FBIOX
XBI
FBIOX vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBIOX vs. XBI - Dividend Comparison
FBIOX's dividend yield for the trailing twelve months is around 1.37%, more than XBI's 0.19% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 1.37% | 1.21% | 0.45% | 0.00% | 0.17% | 0.26% | 0.15% | 0.00% | 0.00% | 0.00% | 6.71% | 10.77% |
XBI SPDR S&P Biotech ETF | 0.19% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
FBIOX vs. XBI - Drawdown Comparison
The maximum FBIOX drawdown since its inception was -71.96%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for FBIOX and XBI. For additional features, visit the drawdowns tool.
Volatility
FBIOX vs. XBI - Volatility Comparison
The current volatility for Fidelity Select Biotechnology Portfolio (FBIOX) is 8.52%, while SPDR S&P Biotech ETF (XBI) has a volatility of 10.33%. This indicates that FBIOX experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.